NCT01232426

Brief Summary

Intra-articular fractures at the dorsal base of the distal phalanx of the hand are usually referred to as Mallet fractures. Treatment of Mallet fractures remains controversial. Although no differences in clinical results are reported between conservative treatment and operative treatment, operative treatment is suggested for fractures involving more than 30% of articular surface. There are many different operative techniques, all with specific disadvantages. The investigators hypothesis is that operative treatment of Mallet fractures with one Meniscus Arrow® has a better outcome than conservative treatment with a Mallet splint.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
84

participants targeted

Target at P50-P75 for not_applicable

Geographic Reach
1 country

6 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 31, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 2, 2010

Completed
4 months until next milestone

Study Start

First participant enrolled

March 1, 2011

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2014

Completed
Last Updated

August 20, 2012

Status Verified

August 1, 2012

Enrollment Period

2.8 years

First QC Date

October 31, 2010

Last Update Submit

August 17, 2012

Conditions

Outcome Measures

Primary Outcomes (2)

  • Extension deficit

    To evaluate the extension deficit after conservative and operative treatment of a Mallet fracture using the Crawford criteria.

    1 year

  • extension deficit

    at every visit, the extension in the DIP joint, is measured

    1 year

Secondary Outcomes (1)

  • wound healing disturbances

    1 year

Other Outcomes (1)

  • nail deformaties

    1 year

Study Arms (2)

Operative

EXPERIMENTAL

operative treatment of a Mallet fracture with a biodegradable Meniscus Arrow®

Procedure: Biodegradable Meniscus Arrow®

Conservative

ACTIVE COMPARATOR

Conservative treatment of a Mallet fracture with a Mallet splint

Device: Mallet splint

Interventions

Closed reduction of the Mallet fracture and fixation with 1 biodegradable meniscus Arrow®

Operative

Conservative treatment of the Mallet fracture with the traditional Mallet splint.

Conservative

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • avulsion fracture involving more than 30% of articular surface

You may not qualify if:

  • (sub)luxation of the distal phalanx
  • patients with a Mallet fracture developed 3 weeks or more prior to presentation
  • patients with a Mallet fracture with failure of conservative treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

st. Elisabeth Hospital

Tilburg, Noord-Barbant, 5022GC, Netherlands

RECRUITING

Amphia Hospital

Breda, North Brabant, 4818CK, Netherlands

NOT YET RECRUITING

Catharaina Hospital

Eindhoven, North Brabant, 5623EJ, Netherlands

NOT YET RECRUITING

Twee Steden Hospital

Tilburg, North Brabant, 5042AD, Netherlands

RECRUITING

Kennemer Gasthuis Hospital

Haarlem, North Holland, 2035RC, Netherlands

NOT YET RECRUITING

Canisius-Wilhelmina Hospital

Nijmegen, 6532SZ, Netherlands

NOT YET RECRUITING

Related Publications (1)

  • Nelis R, Wouters DB. Is the use of biodegradable devices in the operative treatment of avulsion fractures of fingers, the so-called mallet finger advantageous? A feasibility study with meniscus arrows. Open Orthop J. 2008 Nov 3;2:151-4. doi: 10.2174/1874325000802010151.

    PMID: 19478891BACKGROUND

Central Study Contacts

D Wouters, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. D.B. Wouters

Study Record Dates

First Submitted

October 31, 2010

First Posted

November 2, 2010

Study Start

March 1, 2011

Primary Completion

January 1, 2014

Last Updated

August 20, 2012

Record last verified: 2012-08

Locations